Advances and perspectives of next-generation antitumor antibody-based modalities: Structural innovation and target-driven strategies
- DOI
- 10.1016/j.apsb.2026.06.028
- Published
- 2026-10
- Container
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.06.028,
title = {Advances and perspectives of next-generation antitumor antibody-based modalities: Structural innovation and target-driven strategies},
author = {Liangjie Sun and Baixin Xu and Shuhang Wang and Ning Li},
year = {2026},
journal = {Acta Pharmaceutica Sinica B},
doi = {10.1016/j.apsb.2026.06.028},
url = {https://doi.org/10.1016/j.apsb.2026.06.028}
}RIS
TY - JOUR TI - Advances and perspectives of next-generation antitumor antibody-based modalities: Structural innovation and target-driven strategies AU - Liangjie Sun AU - Baixin Xu AU - Shuhang Wang AU - Ning Li PY - 2026 JO - Acta Pharmaceutica Sinica B DO - 10.1016/j.apsb.2026.06.028 UR - https://doi.org/10.1016/j.apsb.2026.06.028 ER -
APA
Sun, L., Xu, B., Wang, S., & Li, N. (2026). Advances and perspectives of next-generation antitumor antibody-based modalities: Structural innovation and target-driven strategies. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.06.028
Source records
- crossref · retrieved 2026-11-10T07:26:05.261Z